Changes in mortality due to Chronic Liver Diseases (CLD) during the COVID-19 pandemic: Data from the United States’ National Vital Statistics System
COVID-19 pandemic had a major negative impact on cirrhosis-specific and CLD-related mortality in the U.S. with significant racial and gender disparities.
Authors
- Dipam Shah
- James M. Paik (ORCID: https://orcid.org/0000-0003-2294-323X)
- Linda Henry (ORCID: https://orcid.org/0000-0002-7833-6124)
- Zobair M. Younossi (ORCID: https://orcid.org/0000-0001-9313-577X)
- Katherine Eberly
- Pegah Golabi (ORCID: https://orcid.org/0000-0001-9818-0983)
Institutions
- Inova Health System (US)
- Inova Fairfax Hospital (US)
- Center for Outcomes Research in Liver Diseases (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1371/journal.pone.0289202
- Citations
- 4
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.55
Funders
- Gilead Sciences